市场调查报告书
商品编码
1466061
封闭式系统输送设备市场:按组件、类型、封闭机制、技术、可用性、最终用途 - 2024-2030 年全球预测Closed System Transfer Devices Market by Component (Bag Access Devices, Syringe Safety Devices, Vial Access Devices), Type (Membrane to Membrane Systems, Needleless Systems), Closing Mechanism, Technology, Usability, End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年封闭式系统输送设备市场规模为11.8亿美元,预计2024年将达到13.2亿美元,2030年将达到26.6亿美元,复合年增长率为12.31%。
封闭式系统输送装置 (CSTD) 旨在安全地将药物从一个储存器转移到另一个储存器,同时降低医护人员、病患和环境接触潜在危险药物或蒸气的风险。这些设备对于处理有毒物质至关重要,特别是在进行化疗和其他有害物质的医院和医疗机构。 CSTD 市场的成长是由职业安全意识的提高、危险药物处理的严格规定以及需要化疗的癌症盛行率的上升所推动的。然而,与实施 CSTD 相关的高成本可能会构成巨大障碍,特别是对于预算限制更为明显的发展中地区的医疗机构。此外,某些设备的复杂性可能需要对医疗保健专业人员进行广泛的培训,从而进一步影响普及。 CSTD 市场的机会因素包括技术进步和创新,从而开发出更有效率、更用户友好且更具成本效益的设备。此外,全球不断扩展的肿瘤学领域为 CSTD 的采用提供了绝佳的机会,因为化疗药物的安全处理至关重要。世界各地加强医疗机构职场安全标准的努力也进一步支持了市场成长前景,凸显了 CSTD 在现代医疗机构中的重要性。
主要市场统计 | |
---|---|
基准年[2023] | 11.8亿美元 |
预测年份 [2024] | 13.2亿美元 |
预测年份 [2030] | 26.6亿美元 |
复合年增长率(%) | 12.31% |
元件袋存取装置的使用激增,以降低溢出和雾化的风险
袋接取装置设计用于牢固地连接至静脉注射 (IV) 袋。其主要作用是将液体药物和溶液安全地转移到静脉输液袋中,而不会使医护人员或周围环境接触到药物。当使用与皮肤接触或吸入可能有害的药物时,这一点尤其重要。袋子存取装置具有防漏和气密机制,可确保药物包含在系统内,从而降低药物溢出和雾化的风险。注射器安全装置旨在防止医疗保健专业人员将药物注射到注射器或给患者服用时可能发生的针刺伤害。这些设备配有安全机制,例如防护罩和可伸缩针头,可自动或手动启动。一旦启动,该机构就会覆盖针头,大大降低意外针刺伤的风险。这可以保护医护人员并防止血液传播疾病的潜在传播。管瓶存取装置用于安全地从小管瓶取出药物。管瓶接入装置确保管瓶和注射器或其他封闭式系统输送装置部件之间的密封连接。与袋子存取装置类似,它们旨在透过提供气密、无洩漏的传输来防止接触危险药物。这些装置通常包括刺穿管瓶橡胶塞的针或尖头,以安全地取出药物,而无需将管瓶打开到外部环境。
最终用途:扩大封闭式系统运输设备在肿瘤诊所和肿瘤中心的使用
医院是CSTD广泛使用的主要环境之一。医院药品处理流程多元、量大,需要严格的安全措施。 CSTD 在保护医护人员免于接触潜在有害药物化合物方面发挥重要作用。在医院中,CSTD 的使用涉及多个部门,包括药房、肿瘤病房和加护病房。肿瘤诊所和中心专门从事癌症治疗,广泛使用化疗药物。鑑于化疗的强效性质以及接触化疗药物可能对健康产生不良影响的可能性,在这些环境中使用 CSTD 对于医护人员和患者的健康至关重要。
区域洞察
在美洲,医疗机构对安全协议(包括 CSTD 的使用)的认识和实施程度很高。这得到了强有力的政府法规的支持,例如美国药典 (USP) 指南,该指南要求在处理危险药物时使用 CSTD。由于强大的资金筹措和研究倡议,该地区是 CSTD 市场製造和不断创新的几家重要公司的所在地。在亚太地区,CSTD 的采用率正在稳步增加,这主要是由于意识的提高和医疗保健法规的逐步收紧。日本、中国和澳洲等国家处于前线,各国政府支持更安全的药品处理。然而,政府的支持和监管程度不如美洲全面。欧洲国家展现了对医护人员安全的坚定承诺,一些国家采用了推荐或强制执行 CSTD 的指南。这包括欧盟(EU)的积极支持。然而,在中东和非洲,儘管政府支持和认识程度各异,但科学技术发展委员会的实施仍处于相对早期阶段。欧洲、中东和非洲地区的 CSTD 生产和供应主要由欧洲公司推动,但寻求扩展到这些市场的国际公司也越来越多。
FPNV定位矩阵
FPNV定位矩阵对于评估封闭式系统运输设备市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对封闭式系统输送设备市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.封闭式系统输送设备市场的市场规模与预测为何?
2.在封闭式系统输送设备市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.封闭式系统输送设备市场的技术趋势与法规结构是什么?
4.封闭式系统输送设备市场主要厂商的市场占有率为何?
5.进入封闭式系统运输设备市场的适当型态和策略性手段是什么?
[195 Pages Report] The Closed System Transfer Devices Market size was estimated at USD 1.18 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 12.31% to reach USD 2.66 billion by 2030.
Closed system transfer devices (CSTDs) are designed to safely transfer medication from one reservoir to another while lowering the risk of exposure to potentially hazardous drugs or vapors to healthcare workers, patients, and the environment. These devices are integral in handling toxic substances, particularly in hospitals and healthcare settings where chemotherapy agents and other hazardous drugs are administered. The growth of the CSTD market is propelled by increasing awareness about occupational safety, stringent regulations for handling hazardous drugs, and the rising prevalence of cancer, necessitating chemotherapy treatments. However, high costs associated with adopting CSTDs can be a substaintial barrier for healthcare facilities, particularly in developing regions with more pronounced budget constraints. Additionally, the complexity of some devices may require extensive training for healthcare professionals, further impacting their widespread adoption. Opportunistic factors for the CSTD market include technological advancements and innovation, which can lead to more efficient, user-friendly, and cost-effective devices. Moreover, the expanding oncology sector worldwide presents significant opportunities for adopting CSTDs, given the critical need for safely handling chemotherapy drugs. The ongoing efforts to enhance workplace safety standards in healthcare settings across the globe further bolster the market's growth prospects, underscoring the importance of CSTDs in modern medical practices.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.18 billion |
Estimated Year [2024] | USD 1.32 billion |
Forecast Year [2030] | USD 2.66 billion |
CAGR (%) | 12.31% |
Component: Burgeoning use of bag access devices reduces the risk of spills or aerosolization
Bag access devices are designed to securely connect to intravenous (IV) bags. Their primary role is to safely transfer liquid medications or solutions into the IV bags without exposing healthcare workers or the surrounding environment to the medication. This is particularly important when handling medications that can be harmful if they come into contact with skin or are inhaled. Bag access devices employ a leak-proof and airtight mechanism to ensure the medication is contained within the system, reducing the risk of spills or aerosolization. Syringe safety devices are engineered to prevent needle-stick injuries, which can occur when healthcare professionals are drawing medication into a syringe or administering it to a patient. These devices come with a safety mechanism, such as a shield or a retractable needle, that activates automatically or manually. Once activated, the mechanism covers the needle, significantly reducing the risk of accidental needle-stick injuries. This protects healthcare workers and helps prevent the potential transmission of blood-borne diseases. Vial access devices are used to withdraw medication from vials safely. They ensure a sealed connection between the vial and the syringe or another closed system transfer device component. Like bag access devices, they aim to prevent exposure to hazardous drugs by providing an airtight and leak-proof transfer. These devices often come with a needle or a spike that pierces the vial's rubber stopper, allowing for safe medication withdrawal without opening the vial to the external environment.
End-Use: Evolving utilization of closed system transfer devices in oncology clinics & oncology centers
Hospitals constitute one of the primary settings where CSTDs are extensively used. The diverse and high-volume nature of drug-handling processes in hospitals necessitates stringent safety measures. CSTDs play a crucial role in protecting healthcare personnel from exposure to potentially harmful drug compounds. In a hospital setting, the utilization of CSTDs spans several departments, including pharmacies, oncology wards, and intensive care units. Oncology clinics and centers specialize in cancer treatment, where chemotherapy drugs are prevalent. Given the potent nature of chemotherapy agents and their potential adverse health effects upon exposure, employing CSTDs in these settings is crucial for the well-being of both healthcare workers and patients.
Regional Insights
In the Americas, there is a high awareness of and implementation of safety protocols in healthcare settings, including using CSTDs. Strong government regulations, such as the United States Pharmacopeia (USP) Chapter guidelines, bolstered this, which mandate using CSTDs when handling hazardous drugs. The region hosts several significant companies that manufacture and constantly innovate in the CSTD market, owing to robust funding and research initiatives. In the APAC region, the adoption of CSTDs is growing steadily, primarily driven by increasing awareness and gradually strengthening healthcare regulations. Countries such as Japan, China, and Australia are at the forefront, with governments supporting safer drug-handling practices. However, the level of government support and regulation is less comprehensive than in the Americas. European countries have shown a strong commitment to healthcare worker safety, with several nations incorporating guidelines recommending or mandating CSTDs. This has been coupled with active support from the European Union in some cases. However, the Middle East and Africa are still in the relatively early stages of adopting these devices, with varying degrees of government support and awareness. The production and availability of CSTDs in the EMEA region are primarily driven by European companies, with a growing presence of international firms looking to expand into these markets.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Closed System Transfer Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Closed System Transfer Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Closed System Transfer Devices Market, highlighting leading vendors and their innovative profiles. These include B. Braun AG, Baxter International Inc., Becton, Dickinson and Company, Caragen Limited, Cardinal Health, Inc., Epic Medical, Equashield LLC, Fresenius Kabi, ICU Medical, Inc., JMS Co., Ltd., Medline Industries, LP, Meissner Corporation, Nipro Corporation, Paragon Care Limited, Sartorius AG, Simplivia Healthcare Ltd., Vygon (UK) Ltd, and Yukon Medical, LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Closed System Transfer Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Closed System Transfer Devices Market?
3. What are the technology trends and regulatory frameworks in the Closed System Transfer Devices Market?
4. What is the market share of the leading vendors in the Closed System Transfer Devices Market?
5. Which modes and strategic moves are suitable for entering the Closed System Transfer Devices Market?